Published in Clin Infect Dis on March 13, 2013
"Test-and-treat" strategy for control of HIV and AIDS can lead to a decrease, not an increase, of multidrug-resistant viruses. Clin Infect Dis (2013) 0.87
Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. Health Aff (Millwood) (2014) 0.85
A call to action for concentrated HIV epidemics. Curr Opin HIV AIDS (2014) 0.84
Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative. Clin Infect Dis (2015) 0.80
Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention. Retrovirology (2013) 0.79
Balancing disease eradication with the emergence of multidrug-resistant HIV in test-and-treat policies. Clin Infect Dis (2013) 0.76
Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study. PLoS One (2015) 0.75
HIV treatment as prevention: contradictory perspectives from dynamic mathematical models. ScientificWorldJournal (2014) 0.75
Reply to Gonzalez-Serna et al. Clin Infect Dis (2013) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr (2005) 15.14
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS (2006) 11.20
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (2000) 5.52
Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ (2010) 4.75
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis (2002) 3.58
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med (2010) 2.71
Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52
Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS (2001) 2.48
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis (2010) 2.28
HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med (2012) 2.21
The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis (2011) 2.20
Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science (2010) 2.19
Update on Department of Health and Human Services guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Hopkins HIV Rep (1999) 1.81
Treating our way out of the HIV pandemic: could we, would we, should we? Lancet (2008) 1.78
A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One (2012) 1.50
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med (2012) 0.99
Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis (2008) 1.99
Linking population-level models with growing networks: a class of epidemic models. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 1.90
Theory versus data: how to calculate R0? PLoS One (2007) 1.22
Mean-field analysis of an inductive reasoning game: application to influenza vaccination. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 1.13
The Affordable Care Act may increase the number of people getting tested for HIV by nearly 500,000 by 2017. Health Aff (Millwood) (2014) 0.93
Private sector provision of oral rehydration therapy for child diarrhea in sub-Saharan Africa. Am J Trop Med Hyg (2014) 0.87
Conscious consideration of herd immunity in influenza vaccination decisions. Am J Prev Med (2013) 0.87
Is there any evidence that syphilis epidemics cycle? Lancet Infect Dis (2008) 0.83
For-profit sector immunization service provision: does low provision create a barrier to take-up? Health Policy Plan (2012) 0.80
Small firms' actions in two areas, and exchange premium and enrollment impact. Health Aff (Millwood) (2012) 0.80
Employer Self-Insurance Decisions and the Implications of the Patient Protection and Affordable Care Act as Modified by the Health Care and Education Reconciliation Act of 2010 (ACA). Rand Health Q (2011) 0.76
Reply to Gonzalez-Serna et al. Clin Infect Dis (2013) 0.75
Activation patterns in superficial layers of neocortex change between experiences independent of behavior, environment, or the hippocampus. Cereb Cortex (2012) 0.75
Modeling employer self-insurance decisions after the Affordable Care Act. Health Serv Res (2013) 0.75
Preventing, Identifying, and Treating Prescription Drug Misuse Among Active-Duty Service Members. Rand Health Q (2017) 0.75